EU_TED process · buyer country BEL · award
Immunoglobuline humaine normale pour administration intraveineuse
['Cliniques universitaires Saint Luc', 'Clinique Saint-Pierre Ottignies', 'Clinique Saint-Jean', "Cliniques de l'Europe"]
Not reported
Data last updated Oct 22, 2026 · Source: Tenders Electronic Daily
- Buyer identifier
- TED_ORGANISATION: 0416885016_5176
- Primary supplier
- ['CSL BEHRING', 'TAKEDA BELGIUM']
- Procurement method
- Not reported
- Tender deadline
- Not reported
- Contract period
- Not reported — Not reported
- Native value
- Not reported
- USD comparison
- Not shown — no auditable FX observation
- Official source
- Open notice ↗
Description
Le marché concerne la fourniture d’immunoglobuline humaine normale pour administration intraveineuse à une concentration de 10%.
Suppliers
- ['CSL BEHRING', 'TAKEDA BELGIUM'] · primary
Official lifecycle
Process timeline
- Award announced
Immunoglobuline humaine normale pour administration intraveineuse
Notice versions
| Publication | Version | Type | Date | Source |
|---|---|---|---|---|
| 731370-2026 | 1 | can-standard | Oct 22, 2026 | Official notice ↗ · XML ↗ |
Lots
| Lot | CPV | Performance | NUTS | Value |
|---|---|---|---|---|
| LOT-0001 | 33651520, 33651520 | BEL, BEL | BE100, BE310 | Not reported |
Contracts
| Contract | Lot | Status | Period | Value |
|---|---|---|---|---|
| CSL BEHRING-LOT-0001: PHARM-2026-845 - 1 | LOT-0001 | Not reported | Not reported — Not reported | Not reported |
Auditable model output
Predictive intelligence
Append-only source history
Source records
| Record | Date | Stages | Fetched |
|---|---|---|---|
| f73872e4-b87a-4d68-81ed-e23ec0319779:1 | Oct 22, 2026 | award_announced | Oct 23, 2026 |